1. Home
  2. SEPN vs IE Comparison

SEPN vs IE Comparison

Compare SEPN & IE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • IE
  • Stock Information
  • Founded
  • SEPN 2022
  • IE 2020
  • Country
  • SEPN United States
  • IE United States
  • Employees
  • SEPN N/A
  • IE N/A
  • Industry
  • SEPN
  • IE Metal Mining
  • Sector
  • SEPN
  • IE Basic Materials
  • Exchange
  • SEPN NYSE
  • IE Nasdaq
  • Market Cap
  • SEPN 1.0B
  • IE 1.1B
  • IPO Year
  • SEPN 2024
  • IE 2022
  • Fundamental
  • Price
  • SEPN $23.30
  • IE $7.20
  • Analyst Decision
  • SEPN Strong Buy
  • IE Buy
  • Analyst Count
  • SEPN 4
  • IE 1
  • Target Price
  • SEPN $43.67
  • IE $14.00
  • AVG Volume (30 Days)
  • SEPN 226.8K
  • IE 468.2K
  • Earning Date
  • SEPN 11-20-2024
  • IE 11-08-2024
  • Dividend Yield
  • SEPN N/A
  • IE N/A
  • EPS Growth
  • SEPN N/A
  • IE N/A
  • EPS
  • SEPN N/A
  • IE N/A
  • Revenue
  • SEPN $981,000.00
  • IE $3,240,000.00
  • Revenue This Year
  • SEPN N/A
  • IE $3.59
  • Revenue Next Year
  • SEPN N/A
  • IE $41.40
  • P/E Ratio
  • SEPN N/A
  • IE N/A
  • Revenue Growth
  • SEPN N/A
  • IE 29.60
  • 52 Week Low
  • SEPN $18.62
  • IE $6.31
  • 52 Week High
  • SEPN $27.47
  • IE $12.98
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • IE 34.52
  • Support Level
  • SEPN N/A
  • IE $7.45
  • Resistance Level
  • SEPN N/A
  • IE $9.76
  • Average True Range (ATR)
  • SEPN 0.00
  • IE 0.52
  • MACD
  • SEPN 0.00
  • IE -0.12
  • Stochastic Oscillator
  • SEPN 0.00
  • IE 17.87

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.

About IE Ivanhoe Electric Inc.

Ivanhoe Electric Inc is a United States-based minerals exploration and development company with a focus on developing mines from mineral deposits located in the United States. The company has three reportable segments; Critical metals segment is focused on mineral project exploration and development with a focus on identifying and developing mineral projects, and ultimately mines, associated with the metals necessary for electrification, The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas and water exploration industries, and The energy storage segment develops, manufactures and installs vanadium flow batteries for grid-scale energy storage. It derives a majority of its revenue from Canada.

Share on Social Networks: